RecruitingNot applicableNCT06722534

Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome

Studying Peutz-Jeghers syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Air Force Military Medical University, China
Intervention: Celecoxib 400mg(drug)
Enrollment: 80 enrolled
Eligibility: 8 years · All sexes
Timeline: 2025 – 2029

Study locations (1)

Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an, Shaanxi, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06722534 on ClinicalTrials.gov

Other trials for Peutz-Jeghers syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT02000089
The Cancer of the Pancreas Screening-5 CAPS5)Study
Johns Hopkins University

See all trials for Peutz-Jeghers syndrome →

← Back to all trials